Predictmedix Inc
QScreen AI Inc. develops artificial intelligence powered technologies for general workplace health and safety, and health care industry. It operates in two segments, Workplace Health and Safety, and Healthcare. The company offers infectious disease symptom screening solutions to identify persons who test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID test… Read more
Predictmedix Inc (PMEDF) - Net Assets
Latest net assets as of October 2025: $-799.17K USD
Based on the latest financial reports, Predictmedix Inc (PMEDF) has net assets worth $-799.17K USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($485.83K) and total liabilities ($1.28 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-799.17K |
| % of Total Assets | -164.49% |
| Annual Growth Rate | N/A |
| 5-Year Change | -251.97% |
| 10-Year Change | N/A |
| Growth Volatility | 46.3 |
Predictmedix Inc - Net Assets Trend (2019–2025)
This chart illustrates how Predictmedix Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Predictmedix Inc (2019–2025)
The table below shows the annual net assets of Predictmedix Inc from 2019 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-01-31 | $-1.32 Million | -817.50% |
| 2024-01-31 | $-143.82K | +6.24% |
| 2023-01-31 | $-153.39K | 0.00% |
| 2022-01-31 | $-153.39K | -117.67% |
| 2021-01-31 | $868.29K | -45.17% |
| 2020-01-31 | $1.58 Million | -5.88% |
| 2019-01-31 | $1.68 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Predictmedix Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1093169300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (January 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.48 Million | % |
| Other Comprehensive Income | $2.45 Million | % |
| Total Equity | $-1.32 Million | 100.00% |
Predictmedix Inc Competitors by Market Cap
The table below lists competitors of Predictmedix Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Garovaglio y Zorraquin S.A.
BA:GARO
|
$3.75 Million |
|
Waja Konsortium Bhd
KLSE:0102
|
$3.75 Million |
|
Splendid Medien AG
F:SPM
|
$3.75 Million |
|
Finansa Public Company Limited
BK:FNS
|
$3.75 Million |
|
BigBen Interactive
PA:BIG
|
$3.75 Million |
|
Fertilizantes Heringer S.A
SA:FHER3
|
$3.75 Million |
|
PT Carsurin Tbk
JK:CRSN
|
$3.75 Million |
|
Palram
TA:PLRM
|
$3.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Predictmedix Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -143,817 to -1,319,526, a change of -1,175,709.
- Net loss of 1,175,709 reduced equity.
- Other comprehensive income increased equity by 1.
- Other factors decreased equity by 1.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.18 Million | -89.1% |
| Other Comprehensive Income | $1.00 | +0.0% |
| Other Changes | $-1.00 | -0.0% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Predictmedix Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-01-31 | $0.03 | $0.02 | x |
| 2020-01-31 | $0.02 | $0.02 | x |
| 2021-01-31 | $0.01 | $0.02 | x |
| 2022-01-31 | $0.00 | $0.02 | x |
| 2023-01-31 | $0.00 | $0.02 | x |
| 2024-01-31 | $0.00 | $0.02 | x |
| 2025-01-31 | $-0.01 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Predictmedix Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-59.85%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -15.91% | 0.00% | 0.00x | 1.00x | $-447.28K |
| 2020 | -139.15% | 0.00% | 0.00x | 1.01x | $-2.46 Million |
| 2021 | -263.91% | -4616.27% | 0.05x | 1.16x | $-2.38 Million |
| 2022 | 0.00% | -5374.58% | 0.05x | 0.00x | $-1.87 Million |
| 2023 | 0.00% | -5904.50% | 0.05x | 0.00x | $-2.05 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.98 Million |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.04 Million |
Industry Comparison
This section compares Predictmedix Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Predictmedix Inc (PMEDF) | $-799.17K | -15.91% | N/A | $3.75 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |